Centogene Statistics
Total Valuation
Centogene has a market cap or net worth of $15.07 million. The enterprise value is $81.77 million.
Market Cap | 15.07M |
Enterprise Value | 81.77M |
Important Dates
The next estimated earnings date is Thursday, September 5, 2024, before market open.
Earnings Date | Sep 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Centogene has 29.00 million shares outstanding.
Shares Outstanding | 29.00M |
Owned by Insiders (%) | 4.57% |
Owned by Institutions (%) | 66.89% |
Float | 11.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.28 |
Forward PS | 0.25 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.52 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02
Current Ratio | 1.02 |
Quick Ratio | 0.89 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.22 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -42.10% |
Return on Capital (ROIC) | -52.39% |
Revenue Per Employee | $140,440 |
Profits Per Employee | -$103,597 |
Employee Count | 384 |
Asset Turnover | 0.57 |
Inventory Turnover | 13.81 |
Taxes
In the past 12 months, Centogene has paid $312,592 in taxes.
Income Tax | 312,592 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.71% in the last 52 weeks. The beta is -0.67, so Centogene's price volatility has been lower than the market average.
Beta (5Y) | -0.67 |
52-Week Price Change | -56.71% |
50-Day Moving Average | 0.41 |
200-Day Moving Average | 0.83 |
Relative Strength Index (RSI) | 70.06 |
Average Volume (20 Days) | 33,724 |
Short Selling Information
Short Interest | 98,232 |
Short Previous Month | 125,884 |
Short % of Shares Out | 0.84% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.01 |
Income Statement
In the last 12 months, Centogene had revenue of $53.93 million and -$39.78 million in losses. Loss per share was -$1.38.
Revenue | 53.93M |
Gross Profit | 18.79M |
Operating Income | -31.42M |
Pretax Income | -38.68M |
Net Income | -39.78M |
EBITDA | -21.23M |
EBIT | -29.51M |
Loss Per Share | -$1.38 |
Balance Sheet
The company has $20.80 million in cash and $87.50 million in debt, giving a net cash position of -$66.70 million or -$2.30 per share.
Cash & Cash Equivalents | 20.80M |
Total Debt | 87.50M |
Net Cash | -66.70M |
Net Cash Per Share | -$2.30 |
Equity (Book Value) | -27.54M |
Book Value Per Share | -0.95 |
Working Capital | 711,227 |
Cash Flow
In the last 12 months, operating cash flow was -$34.58 million and capital expenditures $57,726, giving a free cash flow of -$34.52 million.
Operating Cash Flow | -34.58M |
Capital Expenditures | 57,726 |
Free Cash Flow | -34.52M |
FCF Per Share | -$1.25 |
Margins
Gross margin is 34.84%, with operating and profit margins of -58.26% and -73.77%.
Gross Margin | 34.84% |
Operating Margin | -58.26% |
Pretax Margin | -71.73% |
Profit Margin | -73.77% |
EBITDA Margin | -39.36% |
EBIT Margin | -54.73% |
FCF Margin | -64.01% |
Dividends & Yields
Centogene does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.28% |
Shareholder Yield | -22.28% |
Earnings Yield | -264.05% |
FCF Yield | -229.15% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Centogene has an Altman Z-Score of -3.64 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.64 |
Piotroski F-Score | 3 |